Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting payloads to tumors. Fusion’s clinical portfolio includes: FPI-2265 targeting prostate specific membrane antigen (PSMA) for metastatic castration resistant prostate cancer currently in a Phase 2 trial; FPI-1434 targeting insulin-like growth factor 1 receptor currently in a Phase 1 trial; FPI-2059, a small molecule targeting neurotensin receptor 1 (NTSR1), currently in a Phase 1 trial; and FPI-2068, a bispecific IgG-based EGFR-cMET targeted radioconjugate currently in a Phase 1 trial. In addition, Fusion is pursuing combination programs between RCs and DNA Damage Response Inhibitors (DDRis) and immune-oncology agents. Fusion has a fully operational Good Manufacturing Practice (GMP) compliant state-of-the-art radiopharmaceutical manufacturing facility to meet supply demand for Fusion's growing pipeline of RCs.

Responsibilities

• Support target screening and evaluation process of radioconjugates
• Collect and analyze competitive information (e.g., radioconjugate, Antibody drug conjugates , small molecule drug conjugate activity); summarize and present the analysis results internally to facilitate decision making
• Collaborate with CI team, R&D and various functions at Astra Zeneca to curate radioconjugate data and contribute to development of models that support understanding of radioconjugate space
• Work closely with R&D colleagues to understand gaps in portfolio and technologies; proactively identify opportunities to close gaps and continue to ensure that we remain a leader in radiopharmaceutical theranostics
• Efficiently manage coordinating cross-functional collaboration, establishing timelines, and delivering high quality outputs
• Attend development meetings and provide strategic support, on a needed basis, to R&D and clinical development to ensure timely completion of tasks. Support includes, providing scientific diligence, literature review, data input and analysis
• Have a strong understanding of the scientific landscape and competitive intelligence to ensure visibility to emerging opportunities, changes in the scientific environment, as well as keeping internal stake holders informed and updated
• Partner with external consultants (e.g., CI consultants, strategy consultants, market research analysts) to update landscape and proactively seek out ways to improve assessments
• Lead and manage due diligence processes
• Monitor and track development of relevant new technologies

Qualifications

• Advanced scientific degree (MD or PhD) in life sciences discipline with experience in radiopharmaceuticals (imaging and/or therapy)
• Experience assessing, reviewing and summarizing scientific publications
• Strong analytical, organizational, and project management skills
• Strong grasp of analytic tools with good quantitative analytical abilities
• Excellent communication skills, with proven ability to influence across management levels, functions, and organizations
• Bonus:
  • Post graduate experience in translational programs in life sciences
  • Strong scientific knowledge and clinical acumen; able to engage, understand and translate science into commercial insights and strategic recommendations
  • Strong understanding of development process; solid understanding of regulatory pathways, and other factors that may impact a product’s approval and uptake

All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.